Management of idiopathic crescentic and diffuse proliferative glomerulonephritis: Evidence-based recommendations
Author:
- 1 June 1999
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 55, S33-S40
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Alendronate for the Prevention and Treatment of Glucocorticoid-Induced OsteoporosisNew England Journal of Medicine, 1998
- Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced OsteoporosisNew England Journal of Medicine, 1997
- Goodpasture's syndromeKidney International, 1996
- Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodiesKidney International, 1991
- Rapidly Progressive Glomerulonephritis: Classification, Pathogenetic Mechanisms, and TherapyAmerican Journal of Kidney Diseases, 1988
- Therapy of Anti-Glomerular Basement Membrane Antibody DiseaseMedicine, 1985
- Plasma Exchange in Goodpasture’s SyndromeAmerican Journal of Nephrology, 1982
- Anti-glomerular basement membrane antibody-induced glomerulonephritisKidney International, 1973
- Controlled Trial of Azathioprine and Prednisone in Chronic Renal DiseaseBMJ, 1971
- IMMUNOSUPPRESSIVE THERAPY IN ADULTS WITH PROLIFERATIVE GLOMERULONEPHRITIS Controlled TrialThe Lancet, 1970